Navigation Links
Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines(R)
Date:6/4/2009

lines also incorporate detailed quality measures from the Hospital Quality Alliance (CMS Core Measures) and other national standards-setting groups. Each guideline topic outlines key issues, and provides details on clinical interventions to improve patient outcomes.

About Connolly Healthcare

Connolly Healthcare is a division of leading global recovery audit firm Connolly. Connolly assists clients in the industries of healthcare, retail, commercial, and government in recovering hundreds of millions of dollars annually in erroneous payments to suppliers, vendors, and providers. These errors are endemic to any large organization and result in significant lost dollars every year if not recovered. Recovery auditing is recognized as a best practice and Connolly's expertise places it in a position to propose vital process improvement recommendations to reduce or eliminate future payment errors.

Information on Connolly Healthcare and its services can be obtained at: www.connollyhealthcare.com.

About Milliman Care Guidelines

Milliman Care Guidelines LLC, A Milliman Company, is located in Seattle, and independently develops and produces evidence-based clinical guidelines and a variety of software options that are used by more than 1,000 US and international clients, and support the care of almost two-thirds of US health plan members. Covering the continuum of care, the seven-product Care Guidelines series is updated annually by an experienced team of clinicians. For more information, visit www.careguidelines.com.

About Milliman

Milliman Care Guidelines is a wholly owned subsidiary of Milliman, Inc., which is among the world's largest independent actuarial and consulting firms. Founded in Seattle in
'/>"/>

SOURCE Milliman Care Guidelines
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chocolate Milks Natural Muscle Recovery Benefits Match or May Even Surpass a Specially Designed Carbohydrate Sports Drink
2. RecoveryPlanner and RiskWatch Partner to Deliver an Integrated Business Continuity-Risk Management Software Solution
3. HIV prevention program gets a boost from NIMH recovery act funds
4. Feeding America Partner Support Expedites Disaster Relief and Recovery Efforts
5. Reducing Chronic Diseases Critical to Economic Recovery and Health Reform
6. Scorpion Anti-Venom Speeds Childrens Recovery
7. Enormous Recovery Challenges Remain in Myanmar One Year After Cyclone Nargis
8. SOURCECORP(R) HealthSERVE Unveils Unique Tool for Healthcare Providers to Support Recovery Audit Contractor (RAC) Program Defense
9. Attorney General Eric Holder Honors Florida Doctor and Announces $4.7 Million in Recovery Act Funds for State
10. Looking Forward: Health Information Technology and the American Recovery and Reinvestment Act
11. Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ctoryPharma,Inc.("Victory")announcedtodaythelaunch...y,sNAPRELANfranchise. ,, NAPRELANDoseCardisdesi...ainandinflammationassociatedwithprimarydysmenorrhe...patientssufferingfromrheumatoidarthritisorosteoart...onalanti-inflammatory/analgesicactivityforalimited...
(Date:11/23/2009)...n the November issue of GIE: Gastrointestinal End...nal of the American Society for Gastrointestinal E...y found that Barrett,s esophagus was detected in s...opic screening. Also in this issue, two studies ex...om France, in the largest single-center experience...
(Date:11/23/2009)...build-up of a brain peptide called amyloid-beta. T...us of almost all drug research pursuing a cure for...But that may be counterproductive, says Dr. Inna S...iology and Pharmacology, Sackler Faculty of Medici...beta is also necessary to maintain proper brain fu...
(Date:11/23/2009)...Call/--AnnTaylorStoresCorp.announcedtodaythatitwil...sandGivingcampaign,aholidayfundraisingandawareness...armarksthethirdyearthatAnnTaylor,throughitsANNCARE...mpaignwhereweofferourshoppersanopportunitytohelpsa...hisholidayseason.ClientswhoshopatAnnTaylor,Loft,An...
(Date:11/23/2009)...ed longer-term support than most friends, relative...ing to a study of 160 patients published in the De...Nursing . , Researchers surveyed 55 patients...her with 105 who had had surgery in the last one t...in Tennessee, USA. They wanted to see if there was...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Upending textbook science on Alzheimer's disease 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3
...ntists from University of California have develope...cells which could help in the treatment of spinal ...ing results in the stimulation of nerve cells in l...oung and doesnot grow when it has become old, the ...
...essor Karen Gripp and his team from DuPont Hospita...ad to Costello Syndrome, scientists found that the...it was not observed in the genotype of the parents...don 12 or 13 in the H-ras gene in 85% patients. Th...
...Lancet has published a new study which challenges ...od to the heart. The study asserts that the harm i...benefits. Conventional medical wisdom states that ...ealand cite a large US study published earlier thi...
...search team of scientists at the Columbia Universi...eight when compared to keeping it off. // The key ...ppetite. The hormone helped people to avoid puttin...he metabolic thermostat of the body is reset upwar...
...galese schoolchildren took a pledge to abstain fro...DS Day. The prevailing taboos in the developing na...ntributing towards the disease spreading rapidly. ...courge is continuing to take a heavy toll in the A...
...ish researchers have expressed hope regarding the ...virus. The first phase of the clinical trials have...volunteers. DNA vaccines represent the lates... vaccines precipitate an immune response so that t...
Other Medicine News:Health News:DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope 2
(Date:11/23/2009)...ire-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"...sentationofclinicaltrialdataonNGX426,theCompany,so...ntagonist,atthe12thInternationalConferenceontheMec...r20-21inSanFrancisco.TheresultsofthestudyledbyMark...eCenterforPainMedicineoftheUniversityofCaliforniaa...
(Date:11/23/2009)...ewswire-FirstCall/--NeurobiologicalTechnologies,In...ofdirectorshasdeclaredanextraordinarydividendof$0....,2009tostockholdersofrecordasofNovember30,2009.The...derapprovalofthedissolutionofNTIpursuanttoaplanofc...rdinarydividendof$0.75persharethatwaspaidtoshareho...
(Date:11/20/2009)...swire/ -- The United States Court of Appeals for ... ruling yesterday, approving a settlement in the l...utical litigation against AstraZeneca Pharmaceutic...gi-bin/prnh/20080317/AQM144LOGO ) ,, The ruling...urchased the pharmaceutical giant,s prostate cance...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 1HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 2HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 3Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2
...Mo.--(BUSINESS WIRE)--May 4, 2007 - New data have,...erosis (RRMS),patients treated with COPAXONE(R) (g...osuppression with mitoxantrone experienced a,90 pe...)-monitored,disease activity compared to their bas...ere sustained throughout the 24-month study,period...
...ngland, 4th May 2007 - CeNeS Pharmaceuticals plc,(...ompany, notes,the publication of an independent st... on its Phase II NMDA antagonist, CNS 5161. CeNeS,...r neuropathic,pain. The independent study builds o...CNS 5161. , In the study reported in ,Synapse, Dr...
Other Medicine Technology:Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
Vitreoretinal Viscodissector 90 degrees
Infusion Cannula 6mm
DCR Set
IOL Manipulator - Sinskey
Medicine Products: